Clinical Trial Update: Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluated ixabepilone with and without estramustine in progressive prostate cancer, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Emcyt (estramustine phosphate sodium)
• Ixabepilone (ixabepilone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED